| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1476-5381.2012.02174.X |
| P8608 | Fatcat ID | release_u5c35wzyjbfariihwbthef45l4 |
| P932 | PMC publication ID | 3579291 |
| P698 | PubMed publication ID | 22924591 |
| P2093 | author name string | Yuka Aoki | |
| Atsufumi Kawabata | |||
| Fumiko Sekiguchi | |||
| Daiki Kanaoka | |||
| Maho Tsubota-Matsunami | |||
| Maiko Nakagawa | |||
| Rumi Yamanaka | |||
| Shigeru Yoshida | |||
| Yuta Nishimoto | |||
| P2860 | cites work | Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins | Q24806526 |
| Cell physiology of cAMP sensor Epac | Q27863934 | ||
| Genetic and pharmacological analysis of prostanoid receptor function | Q28186062 | ||
| Attenuated pain responses in mice lacking Ca(V)3.2 T-type channels | Q28260743 | ||
| Networking with AKAPs: context-dependent regulation of anchored enzymes | Q28278715 | ||
| Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels | Q28567108 | ||
| A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1 | Q28568896 | ||
| Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150 | Q28572544 | ||
| TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent | Q30424352 | ||
| T-type voltage-gated calcium channels as targets for the development of novel pain therapies | Q30426595 | ||
| Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway | Q30432705 | ||
| Redox modulation of peripheral T-type Ca2+ channels in vivo: alteration of nerve injury-induced thermal hyperalgesia | Q30433597 | ||
| Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice | Q30434283 | ||
| Protein kinase A activity controls the regulation of T-type CaV3.2 channels by Gbetagamma dimers | Q30436711 | ||
| Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels | Q30444180 | ||
| Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype | Q30856262 | ||
| ACTH induces Cav3.2 current and mRNA by cAMP-dependent and cAMP-independent mechanisms | Q33924353 | ||
| Animal research: reporting in vivo experiments: the ARRIVE guidelines | Q34116755 | ||
| Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice | Q36166689 | ||
| Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons | Q37094339 | ||
| A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1 | Q37438112 | ||
| Prostaglandin E2 and pain--an update | Q37908918 | ||
| Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density | Q38508607 | ||
| Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation | Q39327334 | ||
| Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 | ||
| Involvement of Src kinase in T-type calcium channel-dependent neuronal differentiation of NG108-15 cells by hydrogen sulfide | Q39705773 | ||
| Protein kinase C-mediated inhibition of recombinant T-type Cav3.2 channels by neurokinin 1 receptors | Q39791140 | ||
| Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels | Q39909142 | ||
| In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist | Q40031783 | ||
| Temperature-dependent modulation of CaV3 T-type calcium channels by protein kinases C and A in mammalian cells. | Q40081052 | ||
| CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties | Q40134215 | ||
| Subunit-specific modulation of T-type calcium channels by zinc. | Q40212704 | ||
| Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. | Q40710712 | ||
| Redox modulation of T-type calcium channels in rat peripheral nociceptors | Q40787127 | ||
| Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. | Q40949695 | ||
| The role of PKA and PKCepsilon pathways in prostaglandin E2-mediated hypernociception | Q41424078 | ||
| cAMP decreases steady-state levels of delta-opioid receptor mRNA in NG108-15 cells | Q42442156 | ||
| Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. | Q42501246 | ||
| Protein kinase A-anchoring inhibitor peptides arrest mammalian sperm motility | Q42529103 | ||
| Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain. | Q42946191 | ||
| Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain | Q43024302 | ||
| Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain | Q43062599 | ||
| Modulation of Ca2+ channel current by mu opioid receptors in prefrontal cortex pyramidal neurons in rats. | Q44338364 | ||
| Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin | Q44381194 | ||
| Reversal of experimental neuropathic pain by T-type calcium channel blockers | Q44589954 | ||
| Hydrogen sulfide as a novel mediator for pancreatic pain in rodents. | Q46000821 | ||
| Luminal hydrogen sulfide plays a pronociceptive role in mouse colon | Q46318763 | ||
| Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat. | Q46540769 | ||
| Differential regulation of N- and Q-type Ca2+ channels by cyclic nucleotides and G-proteins | Q48941398 | ||
| Augmentation of Cav3.2 T-type calcium channel activity by cAMP-dependent protein kinase A. | Q50651224 | ||
| Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats. | Q53246817 | ||
| Hydrogen sulfide as a novel nociceptive messenger. | Q53566710 | ||
| Activation of M3 muscarinic receptors inhibits T-type Ca(2+) channel currents via pertussis toxin-sensitive novel protein kinase C pathway in small dorsal root ganglion neurons. | Q54612135 | ||
| MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid | Q80737904 | ||
| Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels | Q83482372 | ||
| ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis | Q83595241 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 734-745 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | AKAP-dependent sensitization of Ca(v) 3.2 channels via the EP(4) receptor/cAMP pathway mediates PGE(2) -induced mechanical hyperalgesia | |
| P478 | volume | 168 |
| Q92857474 | Molecular mechanisms underlying the actions of arachidonic acid-derived prostaglandins on peripheral nociception |
| Q42449128 | Nitric oxide suppresses vascular voltage-gated T-type Ca2+ channels through cGMP/PKG signaling |
| Q38075143 | T-type Ca²⁺ channels in cerebral arteries: approaches, hypotheses, and speculation. |
| Q51115110 | Tacrolimus Triggers Transient Receptor Potential Vanilloid-1-Dependent Relapse of Pancreatitis-Related Pain in Mice. |
Search more.